Skip to product information
1 of 2

P53(Y220C) His Tag Protein, Human

P53(Y220C) His Tag Protein, Human

Catalog Number: UA085060 Brand: UA BIOSCIENCE
Price:
Regular price $360 USD
Regular price Sale price $360 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Species Human
Synonyms TP53, P53, Phosphoprotein p53, Tumor suppressor p53
Accession P04637
Amino Acid Sequence

S94-T312, Y220C with His Tag at the N-Terminus

Expression System E.coli
Molecular Weight 25-35kDa (Reducing)
Purity >95% by SDS-PAGE & HPLC
Conjugation Unconjugated
Tag His Tag
Physical Appearance Liquid
Storage Buffer

50mM Tris, 150mM NaCl, pH7.5, 1mM DTT, 10%Glycerol

Stability & Storage

Stable for 12 months upon stored at -80℃ from the date of receipt. And avoid repeated freeze-thaws cycles.

Reference

1. Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule Reactivator. Cancer Discovery, 15(6), 1159-1179.2. Tornesello, M.L. (2025). TP53 mutations in cancer: Molecular features and therapeutic opportunities. International Journal of Molecular Medicine, 55(1), 5.
2. Tornesello, M.L. (2025). TP53 mutations in cancer: Molecular features and therapeutic opportunities. International Journal of Molecular Medicine, 55(1), 5.
3. Lane, D.P. (1992). Cancer. p53, guardian of the genome. Nature, 358(6381), 15-16.

Background

P53-Y220C is one of the most representative conformational mutants of the TP53 gene, resulting from a substitution of tyrosine to cysteine at position 220. This mutation is located on the surface of the DNA-binding domain (DBD) and does not directly participate in DNA contact. The Y220C mutation creates a surface crevice or “pocket” within the protein core, severely disrupting the thermodynamic stability of the p53 protein. This causes it to undergo conformational changes and aggregate at physiological temperatures, leading to a loss of DNA-binding ability and transcriptional activation function.

In contrast to many other types of mutations, the unique crevice created by the Y220C mutation provides an excellent “druggable” target for the development of small-molecule “chaperone” drugs. These small molecules can precisely bind to this crevice, acting like “glue” to stabilize the folded conformation of the p53 protein, thereby restoring its tumor suppressor function. Consequently, P53-Y220C has become one of the most intensively studied and advanced mutation targets in the field of p53-targeted therapeutics.

Picture

SDS-PAGE

2μg (R: reducing condition, N: non-reducing condition).

RP-HPLC

The purity of P53(Y220C) His Tag Protein, Human is more than 95% determined by RP-HPLC.